文献速递乳房整形与再造显微修复重建

加速康复外科路径用于腹壁下深动脉穿支皮瓣乳房再造:系统综述与Meta分析

Enhanced recovery after surgery pathways for deep inferior epigastric perforator flap breast reconstruction: A systematic review and meta-analysis.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2023-10-15

该系统综述与Meta分析检索5大数据库,纳入14项研究共2102例患者,其中8项研究1679例进入Meta分析。结果显示腹壁下深动脉穿支皮瓣乳房再造中应用加速康复外科路径与住院时间、阿片类药物用量及费用降低相关,且未见严重不良结局证据。

要点

  • 加速康复外科路径与住院时间平均减少1.12天相关(95%CI -1.30至-0.94,n=1627,p<0.001)。
  • 加速康复外科组术后口服吗啡当量减少104.02(95%CI -181.43至-26.61,n=545,p=0.008)。
  • 加速康复外科组费用标准化均数差降低3.54(95%CI -4.43至-2.65,n=527,p<0.001)。

核心结论

  • 腹壁下深动脉穿支皮瓣乳房再造中应用加速康复外科路径与住院时间、阿片类药物用量及患者费用降低相关,且似乎没有证据表明应用该路径与严重不良结局相关。

研究设计与样本

  • 按照系统综述与Meta分析首选报告条目声明,使用预设检索标准查询5个主要医学数据库,统计分析采用Cochrane RevMan v5.4。
  • 共识别466篇文章,14项研究纳入综述,合并样本2102例患者;8项研究纳入Meta分析,合并样本1679例患者。
  • 纳入研究平均使用了乳房再造加速康复外科18条建议方案中的11.69条。

主要发现

  • 加速康复外科组住院时间平均减少1.12天(95%CI -1.30至-0.94,n=1627,p<0.001)。
  • 加速康复外科组术后口服吗啡当量减少104.02(95%CI -181.43至-26.61,n=545,p=0.008)。
  • 加速康复外科组相对对照组费用标准化均数差降低3.54(95%CI -4.43至-2.65,n=527,p<0.001)。
  • 手术时间减少60.46分钟(95%CI -125至4.29,n=624,p<0.07),但未达统计学显著。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Deep inferior epigastric perforator (DIEP) surgery is one of the most difficult breast reconstruction techniques available, both in terms of operating complexity and patient recovery. Enhanced recovery after surgery (ERAS) pathways were recently introduced in numerous subspecialties to reduce recovery time, patient pain, and cost by providing multimodal perioperative care. Plastic surgery has yet to widely integrate ERAS with DIEP reconstruction, mostly due to insufficient data on patient outcomes with this combined approach. METHODS: Five major medical databases were queried using predetermined search criteria according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses statement. Statistical analysis was performed using Cochrane's RevMan (v5.4). RESULTS: A total of 466 articles were identified. A total of 14 studies were included in the review with a combined sample of 2102 patients. Eight studies were included in the meta-analysis with a combined sample of 1679 patients. On average, the included studies utilized 11.69 of 18 suggested protocols for ERAS with breast reconstruction. Our primary outcome, length of stay, was reduced by a mean of 1.12 (95% confidence interval [CI] [-1.30, -0.94], n = 1627, p < 0.001) days in the ERAS group. Postoperative oral morphine equivalents (OME) were also reduced in the ERAS group by 104.02 (95% CI [-181.43, -26.61], n = 545, p = 0.008) OME. The ERAS group saw a significant 3.54 (95% CI [-4.43, -2.65], n = 527, p < 0.001) standardized mean difference cost reduction relative to the control groups. The surgery time was reduced by 60.46 (95% CI [-125, 4.29], n = 624, p < 0.07) min, although this was not statistically significant. CONCLUSIONS: The ERAS pathway in DIEP breast reconstruction is consistently associated with reduced hospital stay, opioid use, and patient cost. Moreover, there appears to be no evidence of serious adverse outcomes associated with the application of the ERAS protocol.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Pierzchajlo N, Zibitt M, Hinson C, et al. Enhanced recovery after surgery pathways for deep inferior epigastric perforator flap breast reconstruction: A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg. 2023. PMID: 37924717. doi:10.1016/j.bjps.2023.10.058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。